Pain Management Therapeutics Market Report (2020-2027) Segmented by Type, Application and region (NA, EU, and etc.)

The pain management therapeutics market is segmented on the lines of its therapeutics, indication and regional. Based on therapeutics segmentation it covers antimigraine agents, non steroidal anti inflammatory drugs, anesthetics, antidepressants, anticonvulsants, opioids and other non narcotic analgesic. Opioidsis further segmented into tramadol, hydrocodones, oxycodaones and others such as methadone, meperidine, fentanyl, codeine, morphine. Based on indication segmentation the pain management therapeutics market covers cancer pain, post operative pain, migraine, arthritic pain, chronic back pain, fibromyalgia and neuropathic pain. The pain management therapeutics marketis geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

Browse Full Report @:


The pain management therapeutics market is expected to exceed more than US$ 83 Billion by 2024; Growing at a CAGR of more than 3.5% in the given forecast period.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, AstraZeneca, Depomed, Inc., Endo Pharmaceuticals, Inc., GlaxoSmithKline plc, Johnson & Johnson, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries Limited. Company profile includes assign such as company summary, financial summary,business strategy and planning, SWOT analysis and current developments.

The scope of the report includes a detailed study of global and regional markets for pain management therapeutics market with the reasons given for variations in the growth of the industry in certain regions.

Pain management is one of the branch of medicine which utilizes an inter punitive approach for improving the superiority and easing the suffering of life of persons who are living with the chronic pain. The usual pain management group consists of clinical psychologists, clinical nurse specialists, physician assistants, occupational therapists, physiotherapists, pharmacists and medical practitioners. Market analyst proposes that almost 20% of world’s population currently suffers from chronic pain. Factors that are increasing number of surgeries, changing lifestyle, increasing geriatric population and increasing prevalence of chronic diseases are responsible for growth in new patients every year.

The major driving factors of pain management therapeutics market are as follows:

Approving health care reforms and regulatory scenario
Increasing approval of pain management therapeutics between end users
Increasing in geriatric population with high risk of different diseases
Growing frequency of chronic pain disorders

The restraining factors of pain management therapeutics market are as follows:

Enduring pain relief from medical devices, alternative therapies and surgical procedures
Prescription drug exploitation
Exclusive rights expiry of entry of generics and key drugs

The Pain management therapeutics Market has been segmented as below:

The Pain management therapeutics Market is Segmented on the lines of Therapeutics Analysis, Indication Analysis and Regional Analysis. By Therapeutics Analysis this market is segmented on the basis of Antimigraine agents, Non steroidal anti inflammatory drugs, Anesthetics, Antidepressants, Anticonvulsants, Opioids, Tramadol, Hydrocodones, Oxycodaones, Others (Methadone, Meperidine, Fentanyl, Codeine, Morphine) and Other non narcotic analgesic.

By Indication Analysis this market is segmented on the basis of Cancer pain, Post operative pain, Migraine, Arthritic pain, Chronic back pain, Fibromyalgia and Neuropathic pain. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.


This report provides:

1) An overview of the global market for pain management therapeutics and related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for pain management therapeutics.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

Request Sample Report from here:


Table of Contents


2 Research Methodology

  1. Global Pain Management Therapeutics Market – Industry Analysis
  2. North America Pain Management Therapeutics Market Revenue, (US$ Mn), 2014–2024
  3. Europe Pain Management Therapeutics Market Revenue, (US$ Mn), 2014–2024
  4. Asia Pacific Pain Management Therapeutics Market Revenue, (US$ Mn), 2014–2024
  5. Rest of World Pain Management Therapeutics Market Revenue, (US$ Mn), 2014–2024
  6. Country Snippet
  7. Company Profiles

9.1. Abbott Laboratories

9.2. AstraZeneca

9.3. Depomed, Inc.

9.4. Endo Pharmaceuticals, Inc.

9.5. GlaxoSmithKline plc

9.6. Johnson & Johnson

9.7. Mallinckrodt Pharmaceuticals

9.8. Merck & Co., Inc.

9.9. Novartis AG

9.10. Pfizer, Inc.

9.11. Purdue Pharma L.P.

9.12. Teva Pharmaceutical Industries Limited

Other Related Market Research Reports:

Patient Monitoring Devices Equipments Systems Market is Determined to Grow US$ 30000 million by 2024

PCR Devices Market is Projected to Reach US$ 5.00 Billion by 2024

Peripheral Vascular & Interventional Cardiology Devices Market is Determined to Cross US$ 25 Billion by 2022

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay


Phone: +1-855-984-1862

Country: United States